Transthyretin amyloid and new treatment options Dec. 15, 2021 Overview Show transcript Overview Mayo Clinic cardiologists Martha Grogan, M.D., Melissa A. Lyle, M.D., and Julie L. Rosenthal, M.D., focus on new transthyretin amyloidosis (ATTR) therapies in this video first shown on Medscape Cardiology. For more information or to refer a patient, visit Mayo Clinic Medical Professionals — Cardiovascular Diseases. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleAmyloidosis, the heart transplant precursor to keep on your diagnostic radarArticleRole of cardiac MRI in the assessment of cardiac amyloidosis VID-20525640 Medical Professionals Transthyretin amyloid and new treatment options